REPORTS

Let’s Pullulate and Expand Your Business

Generic Drugs Market - Global Professional Analysis and Forecast to 2026

Oct 18, 2019  |  208 PAGES  |  REPORT CODE: CMM217804
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Generic Drugs market was valued at 28635 Million US$ in 2018 and is projected to reach 52376 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.84% during the forecast period.

This report presents the market size and development trends by detailing the Generic Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Generic Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Generic Drugs industry and will help you to build a panoramic view of the industrial development.

Generic Drugs Market, By Type:

  • Simple Generic Drugs

  • Super Generic Drugs

  • Biosimilars

Generic Drugs Market, By Application:

  • CNS

  • Cardiovascular

  • Genitourinary/Hormonal Drugs

Some of the leading players are as follows:

  • Fresenius Kabi

  • Sun Pharmaceutical

  • Pfizer (Hospira)

  • Sanofi

  • Aspen Pharmacare

  • Mylan

  • Allergan

  • Novartis-Sandoz

  • Aurobindo

  • Teva Pharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Generic Drugs Market: Technology Type Analysis

  • 4.1 Generic Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Generic Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Simple Generic Drugs

    • 4.3.2 Super Generic Drugs

    • 4.3.3 Biosimilars

5 Generic Drugs Market: Product Analysis

  • 5.1 Generic Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Generic Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Generic Drugs Market: Application Analysis

  • 6.1 Generic Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Generic Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 CNS

    • 6.3.2 Cardiovascular

    • 6.3.3 Genitourinary/Hormonal Drugs

7 Generic Drugs Market: Regional Analysis

  • 7.1 Generic Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Generic Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Fresenius Kabi

    • 9.1.1 Fresenius Kabi Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Sun Pharmaceutical

    • 9.2.1 Sun Pharmaceutical Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer (Hospira)

    • 9.3.1 Pfizer (Hospira) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sanofi

    • 9.4.1 Sanofi Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Aspen Pharmacare

    • 9.5.1 Aspen Pharmacare Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Mylan

    • 9.6.1 Mylan Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Allergan

    • 9.7.1 Allergan Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Novartis-Sandoz

    • 9.8.1 Novartis-Sandoz Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Aurobindo

    • 9.9.1 Aurobindo Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Teva Pharma

    • 9.10.1 Teva Pharma Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 99 Figures and 132 Tables)

  • Figure Simple Generic Drugs Generic Drugs market, 2015 - 2026 (USD Million)

  • Figure Super Generic Drugs Generic Drugs market, 2015 - 2026 (USD Million)

  • Figure Biosimilars Generic Drugs market, 2015 - 2026 (USD Million)

  • Figure CNS market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular market, 2015 - 2026 (USD Million)

  • Figure Genitourinary/Hormonal Drugs market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Generic Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Generic Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Generic Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Generic Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Generic Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Generic Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Generic Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Generic Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Fresenius Kabi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer (Hospira) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aspen Pharmacare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis-Sandoz Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aurobindo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top